A pilot study of the effects of a specialist nurse‐led cognitive‐behavioural therapy service on coping, respiratory function and quality of life for patients with bronchiectasis

Parkin, Claire; Margereson, Carl; McLoughlin, Brendan; Hawking, Ros; Fleming, Sharan

doi:10.1111/j.1365-2702.2005.01402.x

Cited by 6 publications

(9 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The difference in SGRQ scores between the groups remained at the end of the study, but was lower in the CBT group . The shuttle test distance in the CBT group was higher both pre‐and post‐intervention . This study raises the possibility of CBT playing a role in improving overall health in adults with bronchiectasis, but severe limitations of its design mean more robust clinical trials need to be carried out before firm conclusions can be drawn.…”

Section: Role Of the Mdtmentioning

confidence: 86%

“…There was a marked difference in SGRQ scores between the groups at the baseline, likely due to selection bias as ‘sicker’ patients chose to be in the control group. The difference in SGRQ scores between the groups remained at the end of the study, but was lower in the CBT group . The shuttle test distance in the CBT group was higher both pre‐and post‐intervention .…”

Section: Role Of the Mdtmentioning

confidence: 87%

“…Our literature search also revealed a non‐randomized pilot study of specialist nurse‐led cognitive behavioural therapy (CBT) in adult patients with long‐standing and severe bronchiectasis . There were no differences in the levels of anxiety and depression between the groups . There was a marked difference in SGRQ scores between the groups at the baseline, likely due to selection bias as ‘sicker’ patients chose to be in the control group.…”

Section: Role Of the Mdtmentioning

confidence: 98%

See 2 more Smart Citations

Paediatric and adult bronchiectasis: Monitoring, cross‐infection, role of multidisciplinary teams and self‐management plans

Navaratnam

Forrester

et al. 2018

Respirology

View full text Add to dashboard Cite

Bronchiectasis is a chronic lung disease associated with structurally abnormal bronchi, clinically manifested by a persistent wet/productive cough, airway infections and recurrent exacerbations. Early identification and treatment of acute exacerbations is an integral part of monitoring and annual review, in both adults and children, to minimize further damage due to infection and inflammation. Common modalities used to monitor disease progression include clinical signs and symptoms, frequency of exacerbations and/or number of hospital admissions, lung function (forced expiratory volume in 1 s (FEV 1 )% predicted), imaging (radiological severity of disease) and sputum microbiology (chronic infection with Pseudomonas aeruginosa). There is good evidence that these monitoring tools can be used to accurately assess severity of disease and predict prognosis in terms of mortality and future hospitalization. Other tools that are currently used in research settings such as healthrelated quality of life (QoL) questionnaires, magnetic resonance imaging and lung clearance index can be burdensome and require additional expertise or resource, which limits their use in clinical practice. Studies have demonstrated that cross-infection, especially with P. aeruginosa between patients with bronchiectasis is possible but infrequent. This should not limit participation of patients in group activities such as pulmonary rehabilitation, and simple infection control measures should be carried out to limit the risk of cross-transmission. A multidisciplinary approach to care which includes respiratory physicians, chest physiotherapists, nurse specialists and other allied health professionals are vital in providing holistic care. Patient education and personalized self-management plans are also important despite limited evidence it improves QoL or frequency of exacerbations.

show abstract

Section: Role Of the Mdtmentioning

confidence: 86%

Section: Role Of the Mdtmentioning

confidence: 87%

Section: Role Of the Mdtmentioning

confidence: 98%

See 1 more Smart Citation

Paediatric and adult bronchiectasis: Monitoring, cross‐infection, role of multidisciplinary teams and self‐management plans

Navaratnam

Forrester

et al. 2018

Respirology

View full text Add to dashboard Cite

show abstract

“…A small pilot study showed that CBT in patients with bronchiectasis significantly improved quality of life scores and psychosocial adjustment (35). To the best of our knowledge, there are no studies that have examined the effects of CBT among patients with ILD.…”

Section: Relaxation Therapymentioning

confidence: 99%

“…The only studies performed have been done in COPD patients, and these studies have been of varied quality and consequently have a range of results (1). Cognitive behavioural therapy (CBT) has shown potential among patients with COPD, asthma and bronchiectasis (1,(32)(33)(34)(35)(36)(37). Pulmonary rehabilitation has the strongest evidence regarding its benefit in these patients, caused mainly through improved physical capacity (38)(39)(40).…”

Section: Introductionmentioning

confidence: 99%

Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation

Pumar¹

View full text Add to dashboard Cite

Background: Anxiety and depression are psychological conditions that are highly prevalent among patients with chronic lung disease. These conditions are associated with increased morbidity and, in certain groups, increased mortality. Cognitive behaviour therapy (CBT) has shown potential as a treatment of anxiety and depression among patients with COPD, asthma and bronchiectasis. Pulmonary rehabilitation has the strongest evidence regarding its benefit in these patients, mainly through improved physical capacity and education. Consequently, the combination of both treatments (CBT and pulmonary rehabilitation) is promising, with potentially enhanced therapeutic benefits. The primary aim of this thesis was to determine the impact of cognitive behavioural therapy (CBT) as a treatment for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation. The study also assessed risk factors for the presence of anxiety and depression in patients attending pulmonary rehabilitation, the effect of CBT on quality of life and, through a subgroup analysis, the impact of mild cognitive impairment on CBT.Methods: A parallel group, randomised controlled trial (RCT) was conducted, with longitudinal follow-up of 12 months. Participants were screened from the pulmonary rehabilitation program at The Prince Charles Hospital and recruited if they had Geriatric Depression Scale (GDS) ≥4/15 or Geriatric Anxiety Inventory (GAI) ≥3/20, suggestive of depression or anxiety, respectively. In addition to pulmonary rehabilitation, the Intervention group received CBT comprised by two face-to-face sessions and 4 phone sessions, while the Control group received usual care. The main outcome measures were GDS and GAI; secondary outcomes were St. Georges Respiratory Questionnaire (SGRQ), pulmonary rehabilitation attendance and 6 minute walk test (6MWT). Results:The majority of patients attending pulmonary rehabilitation had COPD (58.5%), with the remainder having asthma (19.7%), interstitial lung disease (ILD) (9%) and bronchiectasis (12.4%). Of the patients screened, 25 (13%) had only symptoms of anxiety, 33 (17%) of only depression and 62 (32%) had symptoms of both anxiety and depression. Anxiety and depression were strongly correlated with SGRQ (p<0.01) and pulmonary rehabilitation program attendance. GDS scores were also correlated with 6MWT (p<0.01), past smoking (p<0.01), body-mass index (p<0.01), and body-mass index, airflow obstruction, dyspnea, and exercise capacity index (BODE) scores (p<0.01); while GAI was not correlated with other parameters. 65 patients were randomised to the study (24 in the Intervention group, 41 in the Control group). Of the 24 patients in the Intervention group, 10 (42%) failed to attend pulmonary rehabilitation or withdrew from the study. In the Intervention group, GDS significantly improved, compared to baseline, at the end of rehabilitation (mean difference -3.1, 95% CI -4.39 to -1.7; P<0.01), 3 months follow-up (mean difference -1.46, 95% CI -4.17 to -0.75; P<0.01) and 12 m...

show abstract

Editorial: Intervention studies in JCN

Watson¹

2007

Journal of Clinical Nursing

View full text Add to dashboard Cite

A pilot study of the effects of a specialist nurse‐led cognitive‐behavioural therapy service on coping, respiratory function and quality of life for patients with bronchiectasis

Cited by 6 publications

References 2 publications

Paediatric and adult bronchiectasis: Monitoring, cross‐infection, role of multidisciplinary teams and self‐management plans

Paediatric and adult bronchiectasis: Monitoring, cross‐infection, role of multidisciplinary teams and self‐management plans

Cognitive behavioural therapy (CBT) for patients with chronic lung disease and psychological comorbidities undergoing pulmonary rehabilitation

Editorial: Intervention studies in JCN

Contact Info

Product

Resources

About